A.K. Pharma

A.K. Pharma

hepatocellular carcinoma medicine

Imjudo® (Tremelimumab)

Tremelimumab 300mg Injection — Anti-CTLA-4 Monoclonal Antibody Used in Combination With Imfinzi (Durvalumab) for Unresectable Hepatocellular Carcinoma and Extensive-Stage Small Cell Lung Cancer